Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

IONIS PHARMACEUTICALS INC Logo
Biopharmaceutical firm developing RNA- and DNA-targeted therapeutics for serious diseases.
United States of America
IONS
IOVANCE BIOTHERAPEUTICS, INC. Logo
Biopharmaceutical company developing personalized TIL cell therapies for cancer.
United States of America
IOVA
Ipsen Logo
Biopharmaceutical company developing medicines for oncology, rare diseases, and neuroscience.
France
IPN
IRLAB Therapeutics Logo
Develops novel treatments for Parkinson's disease and other CNS disorders.
Sweden
IRLAB
IRONWOOD PHARMACEUTICALS INC Logo
A healthcare company developing and commercializing therapies for GI diseases.
United States of America
IRWD
ISU Abxis Co., Ltd. Logo
Develops antibody-based immunotherapies for oncology and rare diseases.
South Korea
086890
Iterum Therapeutics plc Logo
Develops and commercializes anti-infectives for multi-drug resistant pathogens.
United States of America
ITRM
Jaguar Health, Inc. Logo
Develops plant-based prescription medicines for human and animal GI diseases.
United States of America
JAGX
Janux Therapeutics, Inc. Logo
Develops tumor-activated T cell engager immunotherapies for cancer treatment.
United States of America
JANX
Japan Tissue Engineering Co., Ltd. Logo
Develops, manufactures, and sells tissue-engineered medical products.
Japan
7774

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.